third generation CCR9 inhibitors (ChemoCentryx)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namethird generation CCR9 inhibitors (ChemoCentryx)
Drug Alias NameCCR9 3G (ChemoCentryx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 9 antagonists
TargetsC-C chemokine receptor type 9
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A